Preparation and characterization of mesoporous bioactive glass/ polycaprolactone nanofibrous matrix for bone tissues engineering

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 11, 2012, Pages 2619-2630

  Lin, Hsiu Mei ^a   Lin, Yi Hsuan ^a   Hsu, Fu Yin ^a  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PERFORMANCE; BIOLOGICAL PROPERTIES; BONE IMPLANT; BONE TISSUE; CELL ATTACHMENTS; COMPOSITE MATRICES; ELECTROSPINNING METHOD; FIBER DIAMETERS; IN-VITRO; MESOPOROUS BIOACTIVE GLASS; MICRO-STRUCTURAL; NANO-FIBROUS; NANOFIBROUS MATRIX; OSTEOBLAST-LIKE CELLS; PROLIFERATION RATE; SIMULATED BODY FLUIDS; TYPE I COLLAGEN;

BIOACTIVE GLASS; BIOMINERALIZATION; BONE; CELL CULTURE; GENE EXPRESSION; NANOFIBERS; TISSUE;

POLYCAPROLACTONE;

GLASS; MESOPOROUS BIOACTIVE GLASS; MOLECULAR SCAFFOLD; POLYCAPROLACTONE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ARTICLE; BIOMINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTROSPINNING; OSSIFICATION; PERFORMANCE; POROSITY; PRIORITY JOURNAL; REACTION ANALYSIS; SYNTHESIS;

ANIMALS; CELL LINE, TUMOR; GLASS; HUMANS; LACTIC ACID; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; NANOFIBERS; NIH 3T3 CELLS; OSTEOBLASTS; POLYESTERS; POLYMERS; TISSUE ENGINEERING; X-RAY DIFFRACTION;

EID: 84871345342     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4734-z     Document Type: Article

References (45)

1. Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future directions. BMC Med. 2011;9:66.
2. Dalby MJ, Childs S, Riehle MO, Johnstone HJ, Affrossman S, et al. Fibroblast reaction to island topography: changes in cytoskeleton and morphology with time. Biomaterials. 2003;24:927-35.
3. Newton D, Mahajan R, Ayres C, Bowman JR, Bowlin GL, et al. Regulation ofmaterial properties in electrospun scaffolds: role of crosslinking and fiber tertiary structure. Acta Biomater. 2009;5:518-29.
4. Ngiam M, Liao S, Patil AJ, Cheng Z, Chan CK, et al. The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering. Bone. 2009;45:4-16.
5. Croll TI, O'Connor AJ, Stevens GW, Cooper-White JJ. Controllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I: physical, chemical, and theoretical aspects. Biomacromolecules. 2004;5:463-73.
6. Heo SJ, Kim SE, Hyun YT, Kim DH, Lee HM, et al. In vitro evaluation of poly e-caprolactone/hydroxyapatite composite as scaffolds for bone tissue engineering with human bone marrow stromal cells. Key Eng Mater. 2007;342-343:369-72.
7. Zhang ZY, Teoh SH, Chong MS, Schantz JT, Fisk NM, et al. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells. 2009;27:126-37.
8. Jo JH, Lee EJ, Shin DS, Kim HE, Kim HW, et al. In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(epsilon-caprolactone) composite materials. J Biomed Mater Res B Appl Biomater. 2009;9:213-20.
9. Hench LL, Polak JM. Third-generation biomedical materials. Science. 2002;295:1014-7.
10. Vallet-Regi M, Ragel CV, Salinas AJ (2003) Glasses with medical applications. Eur J Inorg Chem 1029-1042.
11. Yan X, Yu C, Zhou X, Tang J, Zhao D. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed Engl. 2004;43:5980-4.
12. Li X, Shi J, Dong X, Zhang L, Zeng H. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior. J Biomed Mater Res A. 2008;84:84-91.
13. Chang YL, Stanford CM, Keller JC. Calcium and phosphate supplementation promotes bone cell mineralization: implications for hydroxyapatite (HA)-enhanced bone formation. J Biomed Mater Res. 2000;52:270-8.
14. Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin redbased assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem. 2004;329:77-84.
15. Lao L, Wang Y, Zhu Y, Zhang Y, Gao C. Poly(lactide-co-glycolide)/ hydroxyapatite nanofibrous scaffolds fabricated by electrospinning for bone tissue engineering. J Mater Sci Mater Med. 2011;22:1873-84.
16. Ni S, Chang J, Chou L. A novel bioactive porous CaSiO3 scaffold for bone tissue engineering. J Biomed Mater Res Part A. 2006;76:196-205.
17. Zhu Y, Wu C, Ramaswamy Y, Kockrick E, Simon P, Kaskel S, et al. Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering. Microporous Mesoporous Mater. 2008;112:494-503.
18. Gehron Robey P. The biochemistry of bone. Endocrinol Metab Clin North Am. 1989;18:858-902.
19. Xu C, Inai R, Kotaki M, Ramakrishna S. Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering. Tissue Eng. 2004;10:1160-8.
20. Wutticharoenmongkol P, Sanchavanakit N, Pavasant P, Supaphol P. Preparation and characterization of novel bone scaffolds based on electrospun polycaprolactone fibers filled with nanoparticles. Macromol Biosci. 2006;6:70-7.
21. Zong XH, Kim K, Fang DF, Ran SF, Hsiao BS, et al. Structure and process relationship of electrospun bioabsorbable nanofiber membranes. Polymer. 2002;43:4403-12.
22. Siqueira G, Bras J, Dufresne A. Cellulosic bionanocomposites: a review of preparation, properties and applications. Polymers. 2010;2:728-65.
23. Kokubo T, Takadama H. Simulated body fluid (SBF) as a standard tool to test the bioactivity of implants, In: Bauerlein E, editor. Handbook of biomineralization: biological aspects and structure formation. Wiley-VCH Verlag GmbH, Weinheim, Germany. 2008;doi:10.1002/9783527619443.ch51.
24. Oyane A, Uchida M, Choong C, Triffitt J, Jones J, et al. Simple surface modification of poly(epsilon-caprolactone) for apatite deposition from simulated body fluid. Biomaterials. 2005;26: 2407-13.
25. Oyane A, Uchida M, Yokoyama Y, Choong C, Triffitt J, et al. Simple surface modification of poly(epsilon-caprolactone) to induce its apatite-forming ability. J Biomed Mater Res A. 2005; 75:138-45.
26. Yang F, Both SK, Yang X, Walboomers XF, Jansen JA. Development of an electrospun nano-apatite/PCL composite membrane for GTR/GBR application. Acta Biomater. 2009;5:3295-304.
27. Izquierdo-Barba I, Arcos D, Sakamoto Y, Terasaki O, Lopez-Noriega A, et al. High-performance mesoporous bioceramics mimicking bone mineralization. Chem Mater. 2008;20:3191-8.
28. Choong C, Yuan S, Thian ES, Oyane A, Triffitt J. Optimization of poly(e-caprolactone) surface properties for apatite formation and improved osteogenic stimulation. J Biomed Mater Res Part A. 2012;100A:353-61.
29. Osathanon T, Bespinyowong K, Arksornnukit M, Takahashi H, Pavasant P. Human osteoblast-like cell spreading and proliferation on Ti-6Al-7Nb surfaces of varying roughness. J Oral Sci. 2011;53:23-30.
30. Rechendorff K, Hovgaard MB, Foss M, Zhdanov VP, Besenbacher F. Enhancement of protein adsorption induced by surface roughness. Langmuir. 2006;22:10885-8.
31. Kim HW, Kim HE, Salih V. Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds. Biomaterials. 2005;26:5221-30.
32. Degasne I, Baslé MF, Demais V, Huré G, Lesourd M, et al. Effects of roughness, fibronectin and vitronectin on attachment, spreading, and proliferation of human osteoblast-like cells (Saos-2) on titanium surfaces. Calcif Tissue Int. 1999;64:499-507.
33. Wei J, Heo SJ, Kim DH, Kim SE, Hyun YT, et al. Comparison of physical, chemical and cellular responses to nano-and microsized calcium silicate/poly(epsilon-caprolactone) bioactive composites. J R Soc Interface. 2008;5:617-30.
34. Brown EM. Biology of extracellular Ca2?-sensing receptor (CaR). In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. 2nd ed. San Diego: Academic Press; 2002. 371-88.
35. Dvorak MM, Riccardi D. Ca2as an extracellular signal in bone. Cell Calcium. 2004;35:249-55.
36. Duncan RL, Akanbi KA, Farach-Carson MC. Calcium signals and calcium channels in osteoblastic cells. Semin Nephrol. 1998;18:178-90.
37. Maeno S, Niki Y, Matsumoto H, Morioka H, Yatabe T, et al. The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture. Biomaterials. 2005;26:455-84.
38. Wu C, Ramaswamy Y, Zhu Y, Zheng R, Appleyard R, et al. The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(DL-lactideco-glycolide) films. Biomaterials. 2009;30:2199-208.
39. von der Mark K, Mollenhauer J. Annexin V interactions with collagen. Cell Mol Life Sci. 1997;53:539-45.
40. Krocker D, Perka C, Tuischer J, Funk J, Tohtz S, et al. Effects of tacrolimus, cyclosporin A and sirolimus on MG63 cells. Transpl Int. 2006;19:563-9.
41. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci. 2005;10:822-10837.
42. Ganss B, Kim RH, Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med. 1999;10:79-98.
43. Gordon JA, Tye CE, Sampaio AV, Underhill TM, Hunter GK, et al. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone. 2007;41:462-73.
44. Ogata Y. Bone sialoprotein and its transcriptional regulatory mechanism. J Periodontal Res. 2008;43:127-35.
45. Poser JW, Esch FS, Ling NC, Price PA. Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. J Biol Chem. 1980;255:8685-91.